What Is 2-deoxy-scyllo-inosose synthase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 2-deoxy-scyllo-inosose synthase is an enzyme involved in the biosynthesis of 2-deoxystreptamine, a core component of aminoglycoside antibiotics like kanamycin and neomycin. It catalyzes the cyclization of glucose-6-phosphate into 2-deoxy-scyllo-inosose, a key early step in the pathway. The enzyme is encoded by the *btrC* gene in *Bacillus circulans* and functions optimally at pH 7.5 and 37°C.

Key Facts

2-deoxy-scyllo-inosose synthase catalyzes the first committed step in 2-deoxystreptamine biosynthesis
The enzyme converts D-glucose-6-phosphate into 2-deoxy-scyllo-inosose via an intramolecular aldol condensation
It is encoded by the *btrC* gene in *Bacillus circulans* (discovered in 1998)
Optimal activity occurs at pH 7.5 and temperature of 37°C
This enzyme is essential for the production of aminoglycoside antibiotics such as butirosin

Overview

2-deoxy-scyllo-inosose synthase is a key enzyme in the biosynthetic pathway of 2-deoxystreptamine, a central structural motif in aminoglycoside antibiotics. These antibiotics are clinically significant due to their effectiveness against Gram-negative bacteria and mycobacterial infections.

The enzyme initiates the cyclitol formation process by transforming glucose-6-phosphate into 2-deoxy-scyllo-inosose, setting the stage for downstream modifications. This transformation is critical for the biological activity of antibiotics like butirosin and neomycin.

Substrate specificity: The enzyme specifically acts on D-glucose-6-phosphate, showing no activity with fructose-6-phosphate or other sugar phosphates.
Reaction type: It catalyzes an intramolecular aldol condensation, forming a six-membered carbocyclic ring from a linear sugar precursor.
Gene origin: In *Bacillus circulans*, the enzyme is encoded by the *btrC* gene, identified in a 1998 study of butirosin biosynthesis.
Enzyme class: It belongs to the NAD-dependent sugar phosphate cyclase family, sharing structural motifs with dehydroquinate synthases.
Biological role: Without this enzyme, the biosynthesis of 2-deoxystreptamine cannot proceed, halting antibiotic production in producing strains.

How It Works

The catalytic mechanism of 2-deoxy-scyllo-inosose synthase involves a series of redox and cyclization steps that convert a linear sugar into a cyclic inositol derivative. NAD+ acts as a cofactor, facilitating oxidation and enabling ring closure through enolization and aldol reactions.

Substrate binding: D-glucose-6-phosphate binds to the active site, where it undergoes conformational changes to align for cyclization.
Oxidation step: NAD+ oxidizes the C5 hydroxyl group, forming a keto intermediate essential for enolization.
Enolization: The C2 proton is abstracted, generating an enolate anion that attacks the C1 aldehyde group.
Cyclization: An intramolecular aldol condensation forms the six-membered ring structure of 2-deoxy-scyllo-inosose.
NAD+ regeneration: NADH transfers hydride back in a redox-neutral process, allowing NAD+ to be reused.
Product release: 2-deoxy-scyllo-inosose is released and further modified by downstream enzymes like aminotransferases.

Comparison at a Glance

The following table compares 2-deoxy-scyllo-inosose synthase with related sugar phosphate cyclases in terms of function, structure, and biological context:

Enzyme	Function	Gene	Organism	Similarity
2-deoxy-scyllo-inosose synthase	Converts glucose-6-phosphate to 2-deoxy-scyllo-inosose	btrC	Bacillus circulans	100% (reference)
2-epi-5-epi-valiolone synthase	Involved in validamycin biosynthesis	valA	Streptomyces hygroscopicus	38% amino acid identity
Dehydroquinate synthase	Shikimate pathway enzyme	aroB	Various bacteria	32% identity, same fold
Inositol-1-phosphate synthase	Synthesizes inositol in eukaryotes	INO1	Saccharomyces cerevisiae	29% identity, functional analogy
Queuosine biosynthesis enzyme	Modifies tRNA bases	queE	E. coli	Low structural similarity

Despite low overall sequence identity, these enzymes share a conserved (β/α)₈ barrel fold and NAD-binding motifs, suggesting an evolutionary relationship. The specificity of 2-deoxy-scyllo-inosose synthase for aminoglycoside pathways highlights its niche in secondary metabolism.

Why It Matters

Understanding this enzyme has implications for antibiotic development, metabolic engineering, and combating resistance. Its role in forming the core scaffold of potent antibiotics makes it a target for biotechnological optimization.

Antibiotic production: Enables biosynthesis of butirosin, used in veterinary medicine and studied for human applications.
Metabolic engineering: Cloning *btrC* into heterologous hosts can boost aminoglycoside yields in industrial fermentation.
Drug design: Inhibitors could help regulate antibiotic overproduction or study pathway regulation.
Resistance combat: Engineering novel analogs via modified synthase activity may bypass bacterial resistance mechanisms.
Evolutionary insight: Its structural homology with primary metabolic enzymes suggests horizontal gene transfer events.
Biochemical tool: Used in enzymatic synthesis of inositol derivatives for research and pharmaceutical applications.

As multidrug-resistant infections rise, enzymes like 2-deoxy-scyllo-inosose synthase offer both a window into natural product biosynthesis and a platform for developing next-generation therapeutics through synthetic biology.